Lexicon Pharmaceuticals
Presence
Lexicon Pharmaceuticals is one of the...
Lexicon Pharmaceuticals is a company listed under the stock ticker LXRX (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Lexicon Pharmaceuticals
- Lonnel Coats, President and Chief Executive Officer & Director
- Raymond Debbane, Chairman of the Board
- Philippe Amouyal, Director
Popular executive movements at Lexicon Pharmaceuticals
- Lisa Defrancesco will join the company as Head of Investor Relations and Corporate Strategy on Nov. 13, 2023 (posted on November 2 2023).
- Matthew Cullen has joined the company as Vice President of Value and Access (posted on November 2 2023).
- Alan Nies, Director, will leave the company on Nov. 26, 2023 (posted on October 12 2023).
Click here to view some more movements at Lexicon Pharmaceuticals
Create your alert
to follow the executive moves at Lexicon Pharmaceuticals.
Biotechnology
Lexicon Pharmaceuticals has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Lexicon Pharmaceuticals
- Lexicon Reveals “into the Dark” Awareness Campaign About Vulnerable and Dangerous Period of Time Faced by Heart Failure Patients Following Hospitalization | Lexicon Pharmaceuticals, Inc.Lexicon Reveals “into the Dark” Awareness Campaign About Vulnerable a
- New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at the American College of Cardiology’s 72nd Annual Scientific Session Together with World Heart Federation’s World Congress of Cardiology | Lexicon Pharmaceuticals, Inc.New Analyses
- Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update | Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update
- Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023 | Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2,
- New Analyses of Sotagliflozin to Be Presented at the American College of Cardiology’s 72nd Annual Scientific Session Together with World Heart Federation’s World Congress of Cardiology | Lexicon Pharmaceuticals, Inc.New Analyses of Sotagliflozin to Be Pre
- Lexicon Pharmaceuticals to Participate in the 41st Annual JP Morgan Healthcare Conference | Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals to Participate in the 41st Annual JP Morgan Healthcare Conference
- Lexicon Announces Topline Results from Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia | Lexicon Pharmaceuticals, Inc.Lexicon Announces Topline Results from Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia
- Lexicon Pharmaceuticals to Participate in the 34th Annual Piper Sandler Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference | Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals to Participate in the 34th Annual Piper Sandler Heal
- Lexicon’s LX9211 Shows Significant and Consistent Benefits in the Treatment of Painful Diabetic Neuropathy in Full Results from the Phase 2 RELIEF-DPN-1 Trial Presented at the 16th Annual Pain Therapeutics Summit | Lexicon Pharmaceuticals, Inc.Lexicon’s L
- Lexicon Pharmaceuticals to Participate in the 13th Annual Jefferies London Healthcare Conference | Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals to Participate in the 13th Annual Jefferies London Healthcare Conference
- View more press releases Close
Social media about Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Lexicon Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Lonnel Coats 
Call Lexicon Pharmaceuticals at +1 281...
